Filing Flows › Equillium (EQ) › Recalls, complaints & regulation
Equillium (EQ): clinical trials
Equillium (EQ) beyond its filings: 1 active clinical trial.
Equillium's latest quarter
Equillium, Q4 2024: revenue $4.4M (-52% year over year), operating margin -107.0%, net loss $5.8M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Equillium have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.